Antiangiogenic Metronomic Chemotherapy

Publisher： Karger

E-ISSN： 2296-5262|31|4|161-162

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.31, Iss.4, 2008-03, pp. : 161-162

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Low-Dose Metronomic Chemotherapy: Myth or Truth?

By  

Oncology Research and Treatment, Vol. 29, Iss. 7, 2006-07 ,pp. : 305-307

Karger

Access to resources Recommend Favorite

Preoperative Chemotherapy and Metronomic Scheduling of Chemotherapy in Locally Advanced Oral Cancers

By  

Oncology, Vol. 91, Iss. 1, 2016-07 ,pp. : 35-40

Karger

Access to resources Recommend Favorite

Metronomic Chemotherapy with the COMBAT Regimen in Advanced Pediatric Malignancies: A Multicenter Experience

By  

Oncology, Vol. 82, Iss. 5, 2012-04 ,pp. : 249-260

Karger

Access to resources Recommend Favorite

Five Years of Clinical Experience with Metronomic Chemotherapy: Achievements and Perspectives

By  

Oncology Research and Treatment, Vol. 30, Iss. 12, 2007-11 ,pp. : 606-608

Karger

Access to resources Recommend Favorite

Safety, Tolerability and Biological Effects of Long-Term Metronomic Administration of Non-Cytotoxic Anti-Angiogenic Agents

By  

Oncology, Vol. 77, Iss. 6, 2010-01 ,pp. : 358-365

Karger

Access to resources Recommend Favorite